
You can purchase shares of Cardiol Therapeutics (NASDAQ:CRDL) through any online brokerage.
Other companies in Cardiol Therapeutics’s space includes: Eli Lilly and Co (NYSE:LLY), Johnson & Johnson (NYSE:JNJ), Merck & Co Inc (NYSE:MRK), Novartis AG (NYSE:NVS) and AstraZeneca PLC (NYSE:AZN).
Cardiol Therapeutics has a consensus price target of $9.50.
The stock price for Cardiol Therapeutics (NASDAQ: CRDL) is $1.11 last updated October 30, 2026 at 4:41 PM EDT.
There are no upcoming dividends for Cardiol Therapeutics.
Cardiol Therapeutics does not have any upcoming earnings scheduled.
There is no upcoming split for Cardiol Therapeutics.
Cardiol Therapeutics is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.
Cardiol Therapeutics Inc is a late-stage life sciences company focused on advancing the development of anti-inflammatory and anti-fibrotic therapies for heart disease. Its primary small-molecule candidate, CardiolRx, targets inflammasome pathway...